“Therapeutic and Adverse Effects of Standard-Dose and Low-Dose Meglumine Antimoniate During Systemic Treatment of Syrian Cutaneous Leishmaniasis Patients”. 2016. Journal of Pakistan Association of Dermatologists 24 (2): 115-21. https://doi.org/10.66344/jpad.v24i2.189.